COMMUNIQUÉS West-GlobeNewswire

NewGen to Exercise Option to Convert Ras Al Khaimah Joint Venture into Joint Development, Projected to Boost Profits from US$67 Million to US$123 Million
12/12/2025
Strategic Move to Unlock Further Value and Accelerate Project Momentum with Planned Fundraising and Upcoming Presale Launch BANGKOK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (“NewGen” or the “Company,” [...]
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment
12/12/2025
Vancouver, Canada, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel [...]
Cytokinetics Announces Positive CHMP Opinion of MYQORZO® (Aficamten) for the Treatment of Obstructive Hypertrophic Cardiomyopathy
12/12/2025
Final Decision from European Commission Expected in Q1 2026 SOUTH SAN FRANCISCO, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Committee for Medicinal [...]
Additional Confirmed Response Reported as Part of Amplia Investor Presentation
12/12/2025
HIGHLIGHTS An additional confirmed partial response has been recorded in the ongoing ACCENT trial This brings the confirmed Objective Response Rate to 35% Updated data to be presented at the Life Sciences Virtual [...]
Novo Nordisk A/S: More efficacious dose of Wegovy® recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss
12/12/2025
The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy ® 7.2 mg dose, advancing its availability in the European Union (EU) In the STEP UP programme, people with obesity taking Wegovy ® 7.2 [...]
Parexel Named “Best Contract Research Organization” at 21st Annual Scrip Awards
12/12/2025
Industry leader recognized for excellence and innovation in clinical development RALEIGH, N.C., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) providing insights-driven [...]
Cullgen Reports Positive Results from Phase 1 Study of its Novel Non-Opioid Product Candidate CG001419 for Pain
12/12/2025
IND filing and initiation of Phase 2 clinical trials on track for 1H 2026 SAN DIEGO, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Cullgen Inc. (“Cullgen”), a privately-held, clinical-stage biopharmaceutical company focused on the [...]
Tenaya Therapeutics Announces Pricing of Public Offering
12/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]
MedSpa Marketing Partners Unveils NORA: The AI Revolution in MedSpa Client Engagement
12/12/2025
SACRAMENTO, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- MedSpa Marketing Partners launches NORA, an AI-powered voice agent, transforming client engagement and appointment bookings for medical spas 24/7. Introduction: A [...]
Poppins Launches Integrated Pediatric Care Platform to Support Working Parents with Medical, Behavioral, and Coaching Services
12/12/2025
New York, NY, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Poppins has announced the launch of its integrated pediatric care platform designed to support working parents with medical, behavioral, and coaching services in one [...]
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period
12/12/2025
Company Announcement Transaction adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio Transaction anticipated to be accretive to Genmab’s EBITDA by end of 2029 [...]
EssilorLuxottica va acquérir Signifeye, poursuivant l’extension de son réseau de cliniques ophtalmologiques
12/12/2025
EssilorLuxottica va acquérir Signifeye, poursuivant l’extension de son réseau de cliniques ophtalmologiques Paris, France (12 décembre 2025) – EssilorLuxottica a annoncé aujourd’hui l’acquisition de Signifeye, une [...]
EssilorLuxottica to acquire Signifeye, further growing its ophthalmology clinics footprint
12/12/2025
EssilorLuxottica to acquire Signifeye, further growing its ophthalmology clinics footprint Paris, France (12 December 2025) – EssilorLuxottica announced today the acquisition of Signifeye, a leading Belgian [...]
Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD
12/12/2025
NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that an independent peer-reviewed [...]
Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering
12/12/2025
BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer [...]
Sienna Announces Offering of $250 Million of 3.524% Series F Senior Unsecured Debentures and Redemption of C$175 Million of Series B Senior Unsecured Debentures
12/12/2025
NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES This news release constitutes a “designated news release” for the purposes of Sienna’s amended and restated prospectus [...]
Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium
11/12/2025
For patients whose time to progression on immediate prior therapy was >18 months, median progression-free survival (“PFS”) was 12.4 months with gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and 10.0 [...]
Tevogen CEO Supports Local Law Enforcement with Personal Contribution of 230,000 Company’s Shares of Common Stock
11/12/2025
WARREN, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today announced that its Founder and CEO, Dr. Ryan Saadi has donated 230,000 of his personal shares of [...]
Health Care Advocates Slam Ford Government for Privatizing Surgeries While Pushing Public Hospitals into Deficit
11/12/2025
“A gross misuse of public funds” the Coalition warns as mass protests are planned TORONTO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Ontario’s public hospitals have been pushed into deficit and ordered to find cuts while the [...]

Pages